Eudaimonia Partners, LLC Alterity Therapeutics LTD Transaction History

Eudaimonia Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$0.0 - $0.05 $0 - $1,250	-25,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.0 - $0.03 $0 - $750	25,000 New	25,000 $30,000
Q1 2020 May 05, 2020	SELL	$0.01 - $0.07 $500 - $3,500	-50,000 Closed	0 $0
Q4 2019 May 05, 2020	BUY	$0.01 - $0.02 $500 - $1,000	50,000 New	50,000 $39,000

Ticker ATHE
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,114,600
Market Cap $193M
Description
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.